Items tagged with Access
Webinar: TB and migrant health in EECA - materials now available online (post)
On 3 March 2021, the TB Europe Coalition and the Regional Expert Group on Migration and Health in Eastern Europe and Central Asia (EECA) co-hosted a webinar addressing the barriers migrants face when accessing TB and healthcare services across the EECA countries and the challenges for service delivery.
HIV and TB patients face new barriers to accessing services in COVID-19 era (post)
In the past year, across all non-COVID conditions, routine health care has changed. GPs feel that acute care has been compromised due to their own changed focus, and because patients consult less frequently for non-COVID conditions.
MSF supports TB survivors’ court case for Indian government to override patents on lifesaving TB drugs (post)
New Delhi/Geneva, 20 April 2021 – Next week the Indian government is expected to decide whether it is willing to override patents on two critical tuberculosis (TB) drugs following a court petition filed at the Mumbai High Court by two survivors of TB and activists. If the government is willing to issue the ‘compulsory licenses,’ it would increase access to the newer TB drugs bedaquiline and delamanid for people with multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB in India. The international medical humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF) supports the court petition and urges the Indian government to take this critical step that would allow price-lowering competition among generic manufacturers for drug-resistant (DR) TB medicines in India.
Webinar: TB and migrant health in Western Europe - materials now available online (post)
On 20 April 2021, the TB Europe Coalition and the Regional Expert Group on Migration and Health in Eastern Europe and Central Asia co-hosted a webinar addressing the barriers migrants face when accessing TB and healthcare services across the Western European countries and the challenges for service delivery.
TB Europe Coalition: Panel session on migrant health and TB service delivery (post)
On 21 May 2021, the TB Europe Coalition and the Regional Expert Group on Migration and Health in Eastern Europe and Central Asia will co-host a panel session on migrant health and TB service delivery in the World Health Organization European Region.
Webinar: Challenging patent barriers in accessing new TB treatments - recording now available online (post)
On 30 June 2021, the Third World Network and People's Health Movement conducted a webinar to discuss challenges in accessing affordable new TB treatments, new treatments in the pipeline, the trends in patenting and implications for access.
WHO: New invitation for expression of interest to manufacturers of antituberculosis medicines (post)
To support national and global efforts to increase access to and the affordability of TB care and treatment, the World Health Organization (WHO), together with UNICEF, UNAIDS and Unitaid, invites manufacturers of selected pharmaceutical products to submit expressions of interest for product evaluation to the WHO Prequalification Unit.
Dashboard: Access to the BPaL regimen (post)
TB Alliance launched a webpage to provide information on national-level access to the BPaL regimen - a three-drug, 6-month, all-oral regimen composed of bedaquiline, pretomanid and linezolid for the treatment of highly drug-resistant forms of TB.
Improving availability of patient-friendly TB preventive therapy (post)
August 16, 2021: Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy (TPT).
TB Alliance and Lupin announce commercial partnership for new therapy for highly drug-resistant TB (post)
Agreement between non-profit product development partnership and multinational pharmaceutical company will expand access to new TB drug.
Page 45 of 81 · Total posts: 0
←First 44 45 46 Last→